| Generic Name | Brand Name |
|---|---|
| abciximab | ReoPro |
| eptifibatide | Integrilin |
| tirofiban | Aggrastat |
These medicines prevent the formation of blood clots. They can help prevent blood clots in the coronary arteries after a heart attack.
Glycoprotein IIb/IIIa inhibitors might be used with angioplasty after a heart attack. But they are not used for everyone.
Glycoprotein IIb/IIIa inhibitors may help certain people who have angioplasty after a heart attack, such as people who are at high risk for serious blood clots.1
Glycoprotein IIb/IIIa inhibitors are given in the hospital. So a person is watched closely for any side effects.
Bleeding inside the body is the most common side effect.
See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)
Glycoprotein IIb/IIIa inhibitors are only used in the hospital.
Complete the new medication information form (PDF)(What is a PDF document?) to help you understand this medication.
Citations
- Kushner KG, et al. (2009). 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevated myocardial infarction (Updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (Updating the 2005 guideline and 2007 focused update). A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 120(22): 2271–2306.
Last Revised: April 29, 2011
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
To learn more visit Healthwise.org
© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
RT @sanfordtimg: #sanfordresearch's Dr. Amy Elliott is filling @keloland in on the CRCAIH Annual Summit http://t.co/brWO1zbKUd